Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion type Assertion NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_head.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion description "[Notably, they suggest that Grb2 may represent a promising target for the design of novel CRC therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_provenance.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion evidence source_evidence_literature NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_provenance.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion SIO_000772 24708867 NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_provenance.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion wasDerivedFrom befree-20150227 NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_provenance.
- NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_assertion wasGeneratedBy ECO_0000203 NP433506.RAFkm4Xjyd4q8Wm-UvdiVFzj9-iO_wSPLs9Lyznk5UwWA130_provenance.